Ovarian Hyperstimulation Syndrome: OHSS Symptoms
What is ovarian hyperstimulation syndrome during IVF?
Ovarian hyperstimulation syndrome, or OHSS, is a complication associated with fertility treatments that stimulate the ovaries. The ovaries may enlarge, and changes may develop that cause fluid from the blood vessels to leak into areas such as the abdominal cavity. Therefore, OHSS is not simply synonymous with obtaining a large number of eggs or experiencing abdominal bloating. Diagnosis requires a combined evaluation of symptoms and physical examination and test findings.
The condition may be mild, but some patients may experience serious fluid balance problems, decreased urination, respiratory distress, or clotting complications. Therefore, it is important to report any new or worsening symptoms to the center during treatment. The risk of OHSS should be discussed when planning IVF treatment , and a communication channel accessible to the patient should be established. Knowing the risk does not necessarily mean the treatment will be problematic; the goal is to ensure early diagnosis and appropriate follow-up.
What are the symptoms of OHSS?
Abdominal bloating, fullness, discomfort, and nausea may occur. In more pronounced cases, pain, vomiting, increased abdominal circumference, and fluid accumulation may develop. Decreased urination, shortness of breath, or a general deterioration in condition require closer evaluation. The severity of symptoms and their changes over time are important. A single day's weight or a single ultrasound measurement does not reflect the full severity of the disease.
Changes the patient notices in daily life are valuable. Information such as clothes becoming tighter quickly, urinating less than normal, or vomiting fluids should be reported to the team. However, not all of these findings are unique to OHSS. Other complications after ovarian retrieval can cause similar symptoms. Therefore, instead of self-classifying new symptoms from the internet, it is necessary to discuss them with the treatment team.
What symptoms of OHSS require immediate evaluation?
Difficulty breathing, chest pain, fainting, a marked reduction in urine or inability to urinate, and severe or rapidly worsening abdominal pain require urgent assessment. Painful swelling of one leg or a sudden deterioration in general health also requires prompt help. With persistent vomiting or inability to keep fluids down, contact the healthcare team the same day. If the clinic cannot be reached, seek emergency medical care. Do not wait for a routine follow-up appointment when symptoms are severe.
Especially in cases of sudden, severe pain on one side, pain radiating to the shoulder, or dizziness accompanied by bleeding, various other emergency causes may need to be investigated. Conditions such as ectopic pregnancy , ovarian torsion, or bleeding should not be simply dismissed as "normal swelling after treatment." When presenting to the emergency room, it is important to mention that you are undergoing IVF treatment, the date of egg retrieval, and any medications used. Sharing the information of the treatment center, if available, will facilitate coordination.
Normal bloating after egg retrieval versus OHSS
Mild pain or bloating may occur after egg retrieval. However, progressively worsening symptoms, significant vomiting, decreased urination, or shortness of breath should not be considered a normal recovery. It is not appropriate to wait for worsening with the thought that "everyone experiences this after the procedure." On the other hand, not every mild bloating means a diagnosis of OHSS. Evaluation will differentiate the severity of the symptoms and any accompanying findings.
The patient's previous treatment experience does not guarantee the same course of events. Just because similar sensations resolved quickly in a previous cycle doesn't necessarily mean the symptoms in this new phase are insignificant. It's more helpful to describe what has changed to the follow-up team: details such as the location and duration of pain, increased swelling, fluid intake, and urine volume can be recorded. If necessary, examinations, ultrasound, and blood tests will be planned.
What are early and late OHSS?
The timing of OHSS may be related to triggering medications and pregnancy. Early cases are most often seen in the period following treatment that ensures the final maturation of eggs. In cases that begin later or last longer, the effect of hormones increased during pregnancy may play a role. This distinction affects the follow-up period and risk assessment. However, it is not appropriate for a patient to self-categorize the condition as safe or risky based solely on the number of days.
In some cases where pregnancy does not occur, symptoms may resolve more quickly; longer monitoring may be required if pregnancy occurs. A definite recovery date cannot be given to every patient. Completing medication or several days having passed since egg retrieval does not mean the risk is completely gone. The treatment center should explain which symptoms should be reported and at what stage. The patient can keep a written record of the follow-up plan and contact information.
Factors that increase the risk of OHSS
Polycystic ovary syndrome (PCOS), high ovarian reserve indicators, a history of previous OHSS, and a strong ovarian response during stimulation are important factors in risk assessment. The development of numerous follicles or the retrieval of a high number of eggs may also necessitate a reassessment of the treatment plan. However, a single AMH value or follicle count is not a definitive indicator for everyone. Risk is determined by evaluating baseline characteristics and the response throughout treatment together.
Not every woman with polycystic ovary syndrome ( PCOS) develops OHSS. The increased risk necessitates more careful planning of preventive strategies. Information regarding medications used in the previous cycle, the number of eggs retrieved, and symptoms experienced should be shared with the new center. ASRM's prevention guidelines emphasize early identification of high-risk patients and personalization of the stimulation plan. Patients should not alter their medication dosages based on risk concerns; any changes should be made in consultation with their treatment team.
Is retrieving more eggs always better?
The goal of IVF is not simply to collect as many eggs as possible. Safe treatment, appropriate embryo development, and the probability of a live birth are all considered together. A very strong ovarian response can create additional risks in some patients. Therefore, the physician may change the initial plan during follow-up. Adjusting the dosage or postponing the transfer does not mean the treatment has failed; it may be a decision to protect safety.
Comparing a patient's egg count to that of other people can be misleading. Age, egg maturity, sperm characteristics, and embryo development all differ. The number alone does not guarantee pregnancy. It's important to discuss success criteria and risks together during infertility treatment consultations. Understanding why the treatment team aims for a more controlled response can reduce unnecessary anxiety about plan changes.
How is OHSS diagnosed and its severity assessed?
The physician evaluates the patient's complaints, physical examination, and vital signs. Ultrasound can be used to assess the condition of the ovaries and fluid in the abdomen. Tests such as complete blood count, kidney function, and electrolytes may be necessary. Urine volume, fluid intake, and overall condition are also important during monitoring. The severity of the disease is not determined solely by ovarian size. Individuals with the same ultrasound appearance may have different clinical outcomes.
| Information | Why watch it? |
|---|---|
| Pain, bloating and vomiting | The course of symptoms and the patient's ability to take in fluids are assessed. |
| Urine volume and fluid balance | It provides information about circulation and kidney function. |
| Pulse, blood pressure, and respiration. | It helps to show changes in the overall situation. |
| Ultrasound findings | The ovaries and abdominal fluid are evaluated. |
| Blood tests | Blood density, kidney function, and electrolyte changes are investigated. |
| Access to tracking | It helps in the decision regarding home monitoring or hospitalization. |
Classifications such as mild, moderate, or severe are made by the healthcare team interpreting all findings. It is not reliable for a patient to classify themselves as mild based solely on one set of findings. Findings can change over time. If a person initially deemed suitable for home observation subsequently deteriorates, a reassessment is necessary. The follow-up plan should clearly state through which communication channels these changes will be reported.
How to monitor mild OHSS at home?
Home monitoring is only done when deemed appropriate by the healthcare team. The patient is informed about the symptoms, when to check-ups, and when to return. If requested, weight, waist circumference, fluid intake, and urine output can be recorded. Taking measurements under the same conditions facilitates comparison. However, normal numbers do not negate symptoms such as significant shortness of breath or pain. The clinical condition is always important.
Living alone, distance from the center, or inability to attend follow-up appointments are also factors in the decision. When home monitoring is recommended, having a close relative aware of the situation can be helpful. If symptoms worsen, there should be no delay in waiting for the next measurement. The patient's written instructions and current medication list should be readily available. Briefly and concretely describing when the symptoms started and how they changed during the phone call facilitates the assessment.
How to regulate water intake and diet in OHSS?
In OHSS, fluid balance is assessed on an individual basis. The patient's thirst, vomiting, urine output, and laboratory findings are important. It is not correct to tell everyone to drink very large amounts of water or to completely restrict fluid intake. The recommendations of the treatment team should be followed. If sufficient fluids cannot be taken orally, or if the fluids taken are continuously vomited, evaluation is necessary on the same day. Sometimes, intravenous treatment may be required.
Salty foods, protein drinks, or a specific diet should not be presented as definitive home remedies for OHSS. A tolerated diet based on nausea can be discussed, but dietary recommendations do not replace medical monitoring. Additional restrictions may apply to individuals with kidney or other conditions. Consult your medical team before using over-the-counter products and supplements. The goal is not only to reduce abdominal bloating but also to safely monitor circulation and organ function.
Movement and sexual intercourse during OHSS
When the ovaries are enlarged and tender, temporary restrictions on strenuous exercise, jumping, and sexual intercourse may be recommended. The aim is to reduce the risks associated with straining the ovaries. On the other hand, lying motionless all day is not a suitable approach for everyone. The safe level of activity is determined in consultation with the healthcare team, taking into account the risk of blood clots and overall condition. Exercise should not be undertaken at the expense of pain.
There is no single timeframe for returning to daily tasks or work. The physical demands of the job, transportation, and monitoring needs are assessed. If there is a long travel plan, the team should be informed. When new unilateral pain develops, an evaluation may be requested instead of considering it as ordinary muscle pain caused by movement. It is helpful for the patient to ask in writing which activities are appropriate; this prevents the recommendation of "rest" from being misinterpreted as complete bed rest.
Which medications are used in the treatment of OHSS?
Treatment aims to manage symptoms and prevent complications. Appropriate medications for pain and nausea may be considered, along with anticoagulant therapy or fluid therapy in necessary cases. The choice and duration of medication vary from person to person. Not all patients need to use the same medications. Over-the-counter medications, including pain relievers that can affect kidney function, should not be taken without consulting the treatment team.
The medications used to prevent OHSS are not the same as the monitoring and treatment of advanced OHSS. For example, the use of a risk-reducing medication does not mean that symptoms can be ignored later. The need for blood thinners is also determined according to individual clot risk and the course of the disease. It is not appropriate to follow someone else's prescription or self-medicate. During the follow-up, the purpose of the medication, its possible side effects, and when it should be re-evaluated should be discussed.
When is hospitalization necessary for OHSS?
Significant pain, inability to take fluids, persistent vomiting, respiratory distress, changes in kidney function, or the need for close monitoring may warrant a hospital evaluation. The patient's inability to safely access monitoring may also influence the decision. Hospitalization is not determined solely by laboratory findings. The RCOG's 2026 guidelines emphasize the importance of hospital monitoring and care aimed at preventing complications in more severe cases.
If fluid accumulation in the abdomen causes significant discomfort or affects organ function, drainage may be considered in suitable patients. This procedure is performed with expert evaluation and necessary imaging support; it is not applied in every case of OHSS. In more severe cases, follow-up by different specialists may be required. If the hospital where the patient is admitted is different from the treatment center, the protocols used and the dates of the procedures should be shared. This supports continuity of care and information exchange.
How can OHSS be prevented?
Risk reduction begins with an assessment before treatment starts. A stimulation plan is selected based on ovarian reserve, previous response, and individual risks. During treatment, follicle development and necessary hormone measurements are monitored. In an appropriate protocol, different maturation induction options, risk-reducing medications, or postponement of transfer may be considered. These are strategies chosen by the physician; the patient should not change medications on their own.
ASRM emphasizes the importance of personalized stimulation and appropriate triggering methods in high-risk patients. Risk can be reduced, but no approach should be presented as a guarantee of zero risk for everyone. It is important to maintain regular check-ups and understand medication administration instructions. Any suspicion of incorrect dosage or timing should be reported to the center immediately, rather than withholding information. Reviewing medication packaging and instructions together during the consultation can help prevent administration errors.
Why is freezing all embryos recommended?
Due to a high risk of OHSS or a lack of response, freezing embryos may be recommended instead of performing fresh embryo transfer. This approach is one of the strategies aimed at reducing the risk of prolonged pregnancy-related hormonal surges. Delaying the transfer does not mean that embryos are lost or that treatment is over. Frozen embryo transfer can be planned under appropriate conditions after recovery. The timing depends on individual assessment.
The decision to freeze the embryo may reduce the risk of OHSS, but it cannot be said that all early symptoms will be prevented. Therefore, symptoms should be reported even if a transfer has not been made. It is understandable for the patient to be disappointed by the delay; the medical reasoning behind the decision and the next steps should be explained. The patient can be asked which examination or test will be necessary for the next step. This will create a manageable recovery plan instead of an uncertain waiting period.
Pregnancy and subsequent treatments after OHSS
Developing OHSS does not necessarily mean the pregnancy will have a bad outcome. However, if pregnancy occurs, the symptoms may last longer and require additional monitoring. The follow-up plan is tailored to the severity of the condition and the status of the pregnancy. The prenatal care team should be aware of the OHSS history. New pain or bleeding is evaluated along with all other findings.
Details of previous OHSS are important in future treatment plans. The protocol used, when symptoms began, whether hospitalization was required, and the treatments administered should be recorded. The relationship between new findings in the ovarian assessment and previous treatment can also be considered. A past OHSS experience does not necessarily guarantee the same outcome with new treatment, but it does influence the risk mitigation plan. How this experience will be taken into account can be explicitly asked during the follow-up appointment.
Communication with the clinic during OHSS follow-up
Before starting treatment, an after-hours contact number and emergency contact information should be obtained. Basic information such as the date of the procedure, the onset of symptoms, and information regarding vomiting and urination can be kept ready during the phone call. Daily logs should be shared if requested. However, waiting for a message response is not appropriate for serious symptoms. For findings requiring immediate assessment, direct contact with healthcare services is necessary.
Contact information for scheduled evaluations with Assoc. Prof. Dr. Nazlı Korkmaz can be used. This text does not replace personal follow-up instructions. ASRM, RCOG, ISUOG, NHS, and HFEA resources have been used as a basis. For general patient information, please refer to the ISUOG OHSS statement . Written instructions from the individual's treatment center and current clinical evaluation should be considered.
What information should be prepared for the follow-up interview?
The date ovarian stimulation began, the name and administration time of the last maturation medication, the date of egg retrieval, and whether or not a transfer was performed can be noted. A current list of all medications used should be shared. A brief record of the day symptoms first appeared and whether they increased or decreased afterwards should be provided. If the physician requested daily measurements, these records should be brought; evaluation should not be delayed due to unsolicited measurements.
When visiting another healthcare facility, it is helpful to provide these details instead of simply stating "I underwent IVF." Previous blood test results and ultrasound reports can aid in assessing any changes. The patient is not obligated to self-determine the severity of the condition. Their role is to clearly share symptoms and follow the referral instructions provided. Any unclear parts of the follow-up plan can be revisited; communication outside of regular working hours and emergency procedures should be clearly defined.
Frequently Asked Questions
Does OHSS only occur in IVF?
It is most commonly associated with ovarian stimulation fertility treatments. It can also occur with other stimulation treatments.
Is all bloating after egg retrieval OHSS (Ovarian Hyperstimulation Syndrome)?
No. However, evaluation is necessary if there is increasing pain, vomiting, decreased urination, or shortness of breath.
How long does OHSS last?
It varies depending on the severity and whether or not pregnancy occurs. A definite recovery date cannot be given to everyone.
Can OHSS occur if no embryo transfer is performed?
The risk may decrease, but it cannot be said to disappear completely. Symptoms should still be reported.
Does drinking plenty of water cure OHSS?
It is not a standalone treatment. The fluid regimen is determined based on the clinical condition and tests; excessive intake is not recommended.
Is it necessary to lie down completely during OHSS?
The activity plan is personalized. Avoiding strenuous exercise may be necessary, but complete inactivity is not suitable for everyone.
Will OHSS recur?
The patient's prior history is important in risk assessment. Subsequent treatment is replanned with appropriate measures; recurrence is not certain.
In what situations should I go to the emergency room?
Shortness of breath, chest pain, fainting, significant decreased urination, or severe abdominal pain require immediate evaluation.